Kris Vinckier is a Director and Co-Founder of Paradox Investment Management BV, which manages the investment fund, Paradox Investment Network BV, a Private Privak under Belgian Law. Mr. Vinckier is a seasoned executive in the financial and commercial services sector, who currently serves as the Head of Business Strategy Life and Employee Benefits for Vivium, …
Dr. Kerry Maguire is a healthcare executive who most recently served as the Vice-President for Clinical Operations at the Forsyth Institute in Cambridge, MA. As a public health professional, her focus has been on health disparities of vulnerable populations, primarily children and people living with HIV. Kerry has held faculty roles at Tufts University School …
Mr. Barno is a Capital Advisor and Technology Entrepreneur, and former Executive at Xerox Corporation, IBM, and Institutional Portfolio Manager at UBS Paine Webber. He has advised many Fortune 500 companies including Centel, Hartford Group, Apple Computer, IBM, Microsoft, Boeing, and for the Government of Canada. He founded Press Access ( acquired by Lexis-Nexis) and …
Steven Cordovano brings to BioAegis a sophisticated market perspective and broad investor network gained through years of investment experience as a highly successful fund manager. He has worked in finance and portfolio management for 25 years. Prior to BioAegis, Mr. Cordovano was a Partner with Trivalent Partners, where he assisted emerging growth companies in developing …
VP, Corporate Development and Communications, Steven Cordovano Read More »
Lester Kobzik is a professor emeritus of Pathology at the Harvard Medical School and the Harvard T. H. Chan School of Public Health. His research interests center on lung disease and how the lung defends itself against inhaled toxic and infectious challenges. His work has characterized scavenger receptors on lung macrophages and how they function …
Nineteen-time Emmy-winner John Stossel was hailed by The Dallas Morning News as “the most consistently thought-provoking TV reporter of our time.” Stossel began his career as a business-bashing consumer reporter calling for government regulation. But when he saw that regulation causes new problems, he woke up and started reporting on wonderful things that free markets …
Mark J. DiNubile, MD FIDSA, has recently joined BioAegis Therapeutics as our Chief Medical Officer to propel us forward into late-stage clinical development. He brings to the table the rare combination of clinical and research expertise along with broad pharmaceutical industry experience, coupled with his long-standing dedication to elucidating the clinical utility of plasma gelsolin. …
Chief Medical Officer, Mark J. DiNubile, MD, FIDSA Read More »
Valerie Ceva is the Chief Operating Officer, bringing to BioAegis a record of accomplishments in life science business development, strategic consulting and global venture capital transactions. Prior to BioAegis, Ms. Ceva focused on emerging technology, supporting venture capital firms with investment strategy development and implementation and early stage companies in business model development, venture capital …
Susan Levinson is a co-founder and the CEO of BioAegis, with over 30 years of life sciences consulting and pharmaceutical experience spanning the entire value chain, from the lab bench to marketing. Prior to BioAegis, Dr. Levinson was the President of The Strategic Choice, a management consulting firm she founded after a successful career in …
Chief Executive Officer, Susan L. Levinson, PhD. Read More »
LOCATION:
BioAegis Therapeutics
North Brunswick, NJ
MEDIA INQUIRIES:
Contact: Christine Lagana
clagana@bioaegistx.com
INVESTOR INQUIRIES:
Contact: Steven Cordovano
scordovano@bioaegistx.com
©2023 BioAegis® Therapeutics Inc. | Privacy Policy | Terms of Use